XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis

被引：0

作者：

Fanghui Ye

Zhenfang Liu

Aihua Tan

Ming Liao

Zengnan Mo

Xiaobo Yang

机构：

[1] Guangxi Medical University,Center for Genomic and Personalized Medicine

[2] Guangxi Medical University,Department of Hematology, The First Affiliated Hospital

[3] Guangxi Medical University,Department of Chemotherapy, The Affiliated Tumor Hospital

[4] Guangxi Medical University,Institute of Urology and Nephrology, The First Affiliated Hospital

[5] Guangxi Medical University,Department of Occupational Health and Environmental Health, School of Public Health

来源：

Cancer Chemotherapy and Pharmacology | 2013年 / 71卷

关键词：

Oxaliplatin; Colorectal cancer; Genetic polymorphisms;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：733 / 740

页数：7

共 50 条

[21] MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer [J].

Muniz-Mendoza, R. ;

Ayala-Madrigal, M. L. ;

Partida-Perez, M. ;

Peregrina-Sandoval, J. ;

Leal-Ugarte, E. ;

Macias-Gomez, N. ;

Peralta-Leal, V. ;

Meza-Espinoza, J. P. ;

Moreno-Ortiz, M. ;

Ramirez-Ramirez, R. ;

Suarez-Villanueva, S. ;

Gutierrez-Angulo, M. .

GENETICS AND MOLECULAR RESEARCH, 2012, 11 (03) :2315-2320

[22] Oxaliplatin-based chemotherapy in the management of colorectal cancer [J].

Capdevila, Jaume ;

Elez, Elena ;

Peralta, Sergio ;

Macarulla, Teresa ;

Javier Ramos, Francisco ;

Tabernero, Josep .

EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) :1223-1236

[23] Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population [J].

Jian JiangJun LiangRuyong YaoQingfang LiShanai SongYingying SunTreatment and Research Center of OncologyThe Affiliated Hospital of Medical CollegeQingdao University Qingdao ShandongProvince China .

Clinical Oncology and Cancer Research, 2009, (05) :328-336

[24] Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case–control studies [J].

Li Liu ;

Lin Miao ;

Guozhong Ji ;

Fulin Qiang ;

Zheng Liu ;

Zhining Fan .

Molecular Biology Reports, 2013, 40 :3943-3952

[25] Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: A meta-analysis of the contributions of specific plants [J].

Chen, Menghua ;

May, Brian H. ;

Zhou, Iris W. ;

Sze, Daniel Man-yuen ;

Xue, Charlie C. ;

Zhang, Anthony L. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 105 :18-34

[26] Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients [J].

Liang Fun ;

Zhang Haiping ;

Yin Beibei .

SWISS MEDICAL WEEKLY, 2009, 139 (49-50) :724-728

[27] GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis [J].

Economopoulos, Konstantinos P. ;

Sergentanis, Theodoros N. .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) :1617-1631

[28] RETRACTED: XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis [J].

He, Shengke ;

Zhao, Xiujuan ;

Mu, Ruifang ;

Pan, Zhongjun ;

Mai, Jinglan .

OPEN MEDICINE, 2024, 19 (01)

[29] Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer [J].

Hong, YC ;

Lee, KH ;

Kim, WC ;

Choi, SK ;

Woo, ZH ;

Shin, SK ;

Kim, H .

INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :428-432

[30] Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies [J].

Liu, Li ;

Miao, Lin ;

Ji, Guozhong ;

Qiang, Fulin ;

Liu, Zheng ;

Fan, Zhining .

MOLECULAR BIOLOGY REPORTS, 2013, 40 (06) :3943-3952

← 1 2 3 4 5 →